All I know about GOOGL is the chart. It is days away from forming a very powerful golden cross, and it also formed an inverse head + shoulders. One characteristic about the inverse h&s is it will usually retest right around the price it broke out once or twice before rocketing higher. I don't think you will get a much lower price than Friday's close to get back in, but I don't think it will run away from you immediately either. All I know is with two extremely powerful bullish signals happening at the same time with GOOGL, I won't leave any money on the sidelines. This is heading to $650+ fairly rapidly.
I like BIDU's chart too. My best play is PCLN.
This is only an observation, not a prediction. When I look at the weekly chart for JVA, it is eerily similar toFebruary 2014. It was at this exact point in the 2014 chart that JVA rose from $5 to $8.50 in 7 weeks. Today looks EXACTLY like the point last year just prior to it's ascent.
Personally, I am expecting price and volume to start rising pretty dramatically any day now. I am basing this on nothing other than the chart and it's almost perfect similarity to the last time the stock rose over 60% in less than 2 months. Not sure what can move this stock that much but I really wouldn't be surprised at all to see that kind of rise again starting almost immediately. It would certainly make sense given the recent insider buying and hiring the new PR firm. I still think something really goid is about to happen here.
99% sure you are the one who shorted 200 shares at the closing bell to send it red. It was green a minute before the close. Anybody that wastes their money to manipulate the close will get burned in the long run.
Of course, booking profits now and then missing a huge gain on an announcement on a partnership with a major Pharma is the risk. One of the other, or both, is likely to happen.
My broker sent me the news at 9:04 because i signed up for alerts on this stock. I was actually surprised the stock wasn't moving that much but I did buy even after market open.
This time you are wrong. Short sellers are addicted to NVGN. Shorting NVGN is a more powerful drug than anything in the company's pipeline. On March 31st, the short interest was higher than at any time in the past year, almost 50% higher. I'm sure it's higher now even before the data is released. The stock may be taken down temporarily but this is no longer the dog stock it used to be. They have finally turned the corner.
See you when you decide to buy high over $10.
Not sure that is needed. Anisina reportedly kills cancer cells 20 times faster than existing medications And is expected to work against all cancers. It reportedly is working so well it "blew the socks off" according to the research doctors. If Anisina performs in trials to expectations, NVGN doesn't need anything else to become a multibillion dollar company.
That said, I do expect a partnership with a major Pharma to be announced very soon. That may be the reason NVGN hired PCG Advisory Group a couple of weeks ago.
What would that do to the stock price? I have not followed similar small biotechs that announced partnerships with big pharma.
According to Cantor Fitzgerald, PersonalizeDx "not only provides immediate scale to [Rosetta's] business, but brings top-line growth momentum," Nam said, adding that the price of the transaction compares favorably with other recent, similar deals, such as Cancer Genetics' buy of Gentris for up to $6.25 million, and NeoGenomics' $6 million acquisition of Path Labs.
The reason the stock price was squashed until the deal was finalized is because it is estimated that Rosetta paid PersonalizeDX 500,000 shares of stock as part of the package. Had the price of the stock gone up, then the price of the deal would go up as well. Keeping the stock price low until the deal was finalized saved money. I absolutely believe that is why the stock price started moving the second the deal was completed and we ain't seen nothing yet.
It also seems that the second ROSG completed it's acquisition of PersonalizeDX, the trigger went off for the stock price to rally. Just an observation.
Don't be headfaked by today's action. ROSG is now in play and headed for $6+ short-term. The selloff only served to fill the gap before the next leg higher.
It's gonna be fun here the next couple of weeks. Watch!
The business model is changing. They are going away from hedging and increasing sales on their own branded coffees which should increase margins. They are also quietly generating sales from a licensing deal selling their Don Manuel brand coffee in China through another coffee company that is building shops there.
This insider Knepper last purchased shares in 2007. JVA went up 30% 2 months after he bought. I'm telling you, JVA's stock price will be significantly higher than $5 by June.
two reasons. First, the weekly charts show a bottom has been put in. The last time the chart looked like this, the stock went from $5 to $8.50 in a few months. Second, this is the most insider buying I've ever seen. It is the most since at least 2005, perhaps even in the company's history. Regardless of the size of purchases, JVA insiders have never purchased shares for show. The stock has always risen within a couple of months after their purchases.
Between retaining Liolios Group, insider purchases and a weekly chart that appears ready to break out, we may finally be getting ready for the rally we have all been waiting for. All I know is JVA's stock price could double and it still would not be overpriced at a P/e of 16. That is how ridiculously undervalued this company has become.
"Do you not think that insiders sometimes buy shares for show?"
Before recently, do you know the last time any of the Gordon's brothers bought JVA shares?
I went through the SEC filings and the last time a Gordon brother bought shares on the open market was 10 years ago. Your assertion that they are buying shares now to dupe investors into buying their company is false. Otherwise, they would have made token purchases in the past 10 years to fool investors into boosting their share price.
I will wait a couple of months to see how this plays out. However, the fact that both Gordon brothers bought shares on the open market is so rare I had to go back 10 years to find another time it happened. My guess is they either know of good news coming or are convinced, like many of us here, that their shares are extremely undervalued.